文献速递胸部肿瘤放疗放疗物理与技术

致死性放射性肺炎:文献综述与病例系列

Fatal Radiation Pneumonitis: Literature Review and Case Series.
PubMed 文献 · Adv Radiat Oncol · 2019-08-31

该研究基于3例接受常规分割放疗的非小细胞肺癌患者,结合文献综述分析致死性放射性肺炎的临床特征与危险因素。致死性肺炎症状出现更早、对激素反应差且易在减量后复发,影像超出高剂量区并累及对侧肺,低剂量与高剂量肺体积均为剂量学危险因素。

要点

  • 致死性放射性肺炎症状出现更早,常对激素无反应或减量后复发
  • 影像改变超出高剂量区并累及对侧肺
  • 低剂量与高剂量肺体积均为剂量学危险因素

核心结论

  • 致死性放射性肺炎虽罕见,但低剂量与高剂量肺体积均为其剂量学危险因素,临床与影像学基础因素亦起重要作用。
  • 肺内最佳剂量分布(大剂量小体积vs小剂量大体积)这一问题历经数十年仍未被解决。

研究设计与样本

  • 病例系列:3例非小细胞肺癌患者接受常规分割放疗,2例采用容积旋转调强放疗、1例采用调强放疗。
  • 结合文献综述,聚焦肺癌常规分割与立体定向放疗中5级肺炎的相关报道。

主要发现

  • 3例患者全肺及对侧肺5 Gy体积均较高,均在放疗结束后2至5个月死于肺炎。
  • 致死性肺炎患者症状出现早于低级别肺炎,常对激素治疗无反应或减量后复发。
  • 影像特征超出高剂量区并累及对侧肺。
  • 立体定向放疗患者中,间质性肺病被描述为危险因素。

关键数值与推荐

  • 剂量学危险因素包括低剂量肺体积与高剂量肺体积两方面。
  • 当同时遵循低剂量与高剂量肺体积约束时,即使采用调强放疗并同步化疗,5级肺炎风险已被显示为低。

临床怎么用

  • 计划评估时应同时关注低剂量与高剂量肺体积约束,而非仅看高剂量区。
  • 对致死性肺炎应警惕症状早发、激素反应差及减量后复发,影像超出高剂量区并累及对侧肺时需提高警觉。
  • 立体定向放疗患者需关注间质性肺病这一临床危险因素。

局限性

  • 本文为基于3例病例的文献综述,样本量小。
  • 肺内最佳剂量分布问题仍未解决。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Fatal radiation pneumonitis is a rare event. In recent years, higher incidences of grade 5 pneumonitis have been reported. Based on 3 cases in our clinic, a literature review was performed to assess specific clinical features and risk factors for fatal pneumonitis. METHODS AND MATERIALS: Three patients with nonsmall cell lung cancer were treated with conventionally fractionated radiation therapy, 2 with volumetric modulated arc therapy and one with intensity modulated radiation therapy. All 3 patients had high volumes of 5 Gy in the total lung and contralateral lungs. Patients died of pneumonitis between 2 and 5 months after the end of radiation therapy. A literature review focused on grade 5 pneumonitis was performed for conventionally fractioned and stereotactic radiation therapy for lung cancer. RESULTS: Patients with grade 5 pneumonitis develop symptoms sooner than lower grade pneumonitis. Symptoms often do not respond to steroid treatment or return after steroid taper. Imaging features extend beyond the high dose area and involve the contralateral lung. Dosimetric risk factors include both low dose and high dose lung volumes. For patients undergoing stereotactic radiation therapy interstitial lung disease has been described as a risk factor. CONCLUSIONS: Despite decades of investigating radiation pneumonitis, the question of the optimum dose distribution in the lung, a large dose to a small volume versus a small dose to a large volume, is still unresolved. When both low and high dose lung volume constraints are followed, the risk for grade 5 pneumonitis has been shown to be low even with intensity modulated radiation therapy and concurrent chemotherapy. In addition to dose factors, underlying clinical and radiographic parameters play an important role for the development of grade 5 pneumonitis.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Keffer S, Guy CL, Weiss E, et al. Fatal Radiation Pneumonitis: Literature Review and Case Series. Adv Radiat Oncol. 2019. PMID: 32280824. doi:10.1016/j.adro.2019.08.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。